Monsanto Co. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co.

MTC 2.850

+1.8%

11:46 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (1044)	2/2/1999 12:23:00 AM
From: John R. Sashko	Read Replies (2) of 2539

I believe that the number of Celebrex prescriptions will continue to soar. Many physicians are still not aware of this drug. I just returned from a CME at Whistler. When the rheumatologist spoke about Celebrex the audience began to salivate! My invitation to a Searle-Pfizer dinner lecture on Feb 22nd states "New! Advances in the Treatment of Arthritis- Breakthrough COX-2 Technology!!!" Funny it doesn't mention Celebrex anywhere. The FDA approved Celebrex for the treatment of OA and RA. However, once a medication is on the market, physicians can prescribe Celebrex for other conditions. I believe in the geriatric population it will quickly become the standard of care for pain management where an NSAID would have been used in the past. I felt comfortable prescribing it to an 88 yo with a frozen shoulder last week. One of my partners states he now has a new tool to use when the narcotic seekers come in for a visit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next